Global POC Diagnostics Market 2017-2021
About POC Diagnostics
POC diagnostic tests help in reducing the time between diagnosis and treatment of a disease. These tests are either antibody-based or microbial particle-based. Healthcare professionals or nurses collect the testing samples from the patient, perform analysis, and record the result. These tests include enzyme-linked immunosorbent assay (ELISA), agglutination tests, and lateral flow immunochromatography. In 2016, the global POC diagnostics market held 13.09% of the global IVD market.
Technavio’s analysts forecast the global POC diagnostics market to grow at a CAGR of 7.95% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global POC diagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume and value of POC diagnostics.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global POC Diagnostics Market 2017-2021
Technavio recognizes the following companies as the key players in the global POC diagnostics market: Alere, F. Hoffmann-La Roche, Siemens Healthineers, Abbott, PTS Diagnostics, and Danaher.
Other Prominent Vendors in the market are: Accriva Diagnostics, Aesynt, CoaguSense, Diagon, DiaSys, EKF Diagnostics, Epistem, FUJIFILM, Helena Laboratories, HemoSonics, iLine Microsystems, Jant Pharmacal, LifeScan, Micropoint Bioscience, Nova Biomedical, Philips healthcare, PixCell, Quidel, Radisens Diagnostics, Securetec, Detektions-Systeme,Sysmex, and TaiDoc.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is Emerging technology of molecular diagnosis in POC. Molecular testing is used for screening specific genetic mutations. It involves analyzing the human DNA, RNA, chromosomes, specific metabolites, and proteins for detecting heritable disease-related genotypes, mutations, karyotypes, or phenotypes for clinical purposes. The next-generation devices follow molecular techniques such as Polymerase Chain Reaction (PCR) to provide infectious disease testing result to be used in POC diagnostic device. One of the emerging molecular testing assays is the Cepheids's GeneXpert System. This small bench-top device helps in enhancing the performance of the real-time quantitative PCR.”
According to the report, one of the major drivers for this market is Growing focus on diagnosing life-threatening conditions. There is an unmet clinical need for timely diagnosis of life-threatening diseases like sepsis and acute cardiac infarction. Serious conditions with high mortality rate also incur greater patient costs and strengthen the impetus for rapid POC diagnosis.
Further, the report states that one of the major factors hindering the growth of this market is Lack of skilled professionals to carry out POC diagnosis. Most POC diagnostic tests are performed in hospitals and physician's offices by highly skilled staff. The popularity of POC diagnostic testing is growing in developing countries. Most medical professionals lack knowledge about this technology and its benefits. There is a lack of knowledge about the ways of handling the patient during the POC testing.
Alere, F. Hoffmann-La Roche, Siemens Healthineers, Abbott, PTS Diagnostics, Danaher, Accriva Diagnostics, Aesynt, CoaguSense, Diagon, DiaSys, EKF Diagnostics, Epistem, FUJIFILM, Helena Laboratories, HemoSonics, iLine Microsystems, Jant Pharmacal, LifeScan, Micropoint Bioscience, Nova Biomedical, Philips healthcare, PixCell, Quidel, Radisens Diagnostics, Securetec, Detektions-Systeme, Sysmex, and TaiDoc
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook